This article is more than 5 years old. Information may no longer be current.
Top stories in cardiology: Model predicts CVD risk for patients taking statins, former NFL players at high risk for atrial fibrillation
Click Here to Manage Email Alerts
Among the top stories in cardiology last week were presentations from the American Society for Preventive Cardiology Congress on CVD Prevention on a model that was shown to predict 5-year atherosclerotic CVD risk in patients on statin therapy, data suggesting SGLT2 inhibitors may have great potential in reducing heart failure in diabetes and a study that found postmenopausal women with obesity or overweight had elevated risk for heart failure regardless of whether they were metabolically healthy or unhealthy.
Other top stories were the FDA designating a product recall of several intra-aortic balloon pumps as a class 1 recall and a study that found retired National Football League players were more than five times as likely to have atrial fibrillation compared with men in the general population.
Model predicts 5-year atherosclerotic CVD risk in patients on statin therapy
SAN ANTONIO — Researchers developed an atherosclerotic CVD risk score that was shown to estimate residual atherosclerotic CVD risk among adults with prior CVD who are on statin therapy. Read more.
SGLT2 inhibitors may have great potential in reducing heart failure in diabetes
SAN ANTONIO — Several studies on SGLT2 inhibitors have shown that they may be able to reduce heart failure in patients with diabetes, according to a presentation at the American Society for Preventive Cardiology Congress on CVD Prevention. Read more.
Obesity, overweight predict heart failure risk in postmenopausal women despite metabolic health
SAN ANTONIO — Postmenopausal women with obesity or overweight had elevated risk for heart failure regardless of whether they were metabolically healthy or unhealthy, a speaker said. Read more.
FDA designates recall of intra-aortic balloon pumps as class 1
The FDA has designated Maquet/Datascope’s product recall of several intra-aortic balloon pumps as a class 1 recall, the most serious kind. The recall affects 22,853 devices used in patients undergoing cardiac and noncardiac surgery and for the treatment of patients with heart failure complications or acute coronary syndrome. Read more.
Former NFL players at great risk for atrial fibrillation
Retired National Football League players were more than five times as likely to have atrial fibrillation compared with men in the general population, according to findings published in the Journal of the American Heart Association. Read more.